The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Mogil’nitskaya L.A.

Khmel’nitsk Regional Hospital, Ukraine

Serum levels of fibronectin in obese and non-obese women with polycystic ovary syndrome

Authors:

Mogil’nitskaya L.A.

More about the authors

Journal: Problems of Endocrinology. 2016;62(4): 27‑31

DOI: 10.14341/probl201662427-31

Views: 667

Downloaded: 2

Download PDF (RU)
Contact the author
Table of contents

SERUM LEVELS OF FIBRONECTIN IN OBESE AND NON-OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME
SERUM LEVELS OF FIBRONECTIN IN OBESE AND NON-OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME

To cite this article:

Mogil’nitskaya LA. Serum levels of fibronectin in obese and non-obese women with polycystic ovary syndrome. Problems of Endocrinology. 2016;62(4):27‑31. (In Russ.)
https://doi.org/10.14341/probl201662427-31

МСФ на ЯМ
Close metadata

Aim - to investigate serum level of fibronectin in obese and non-obese women with polycystic ovary syndrome (PCOS) as a marker of endothelial dysfunction, and the relationship of that factor to the endothelium-dependent dilatation and other risk factors for cardiovascular disease. Material and methods. We study 62 women: 45 - with PCOS (23 obese women, 22 - non-obese) and 20 - a control group. Serum level of fibronectin was determined by ELISA. Endothelium-dependent dilatation was measured by test of Celermajer. Data was presented as mean ± SD. Results. We found an elevation of serum level of fibronectin in obese women with PCOS compared to control (258,12±48,47 and 196,34±46,68 pmol/ml respectively; р<0,05), in non-obese women compared to control (227,62±35,36 and 196,34±46,68 pmol/ml respectively, р<0,05). Serum level of fibronectin in obese was higher than non-obese women (258,12±48,47 и 227,62±35,36 pmol/ml respectively, р<0,05). Also, there are a correlation between the serum levels of fibronectin and BMI, HOMA index, lipid metabolism, androgens in PCOS women obese and non-obese (p<0,05). Conclusion. Serum level of fibronectin is elevated in obese and non-obese women with PCOS. Hyperandrogenemia, dyslipidemia, insulin resistence, obesity appears to be significant factor to contributing elevation of fibronectin. The revealed change of fibronectin could reflect an endothelial dysfunction in PCOS.

Keywords:

fibronectin
polycystic ovary syndrome
insulin resistance
endothelial dysfunction

Authors:

Mogil’nitskaya L.A.

Khmel’nitsk Regional Hospital, Ukraine

List of references:

  1. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370(9588):685-697.  doi: 10.1016/S0140-6736(07)61345-2
  2. Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006;113(10):1148-1159. doi: 10.1111/j.1471-0528.2006.00990.x
  3. Orio FJR, Palomba S, Spinelli L, et al. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. J Clin Endocrinol Metab. 2004;89(8):3696-3701. doi: 10.1210/jc.2003-032049
  4. Kelly CJ, Speirs A, Gould GW, et al. Altered vascular function in young women with polycystc ovary syndrome. J Clin Endocrinol Metab. 2002;87(2):742-746.  doi: 10.1210/jcem.87.2.8199
  5. Escobar-Morreale HF, Luque-Ramirez M, San Millan JL. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev. 2005;26(2):251-282. doi: 10.1210/er.2004-0004
  6. Tzeng CR, Chang YC, Chang YC, et al. Cluster analysis of cardiovascular and metabolic risk factors in women of reproductive age. Fertil Steril. 2014;101(5):1404-1410. doi: 10.1016/j.fertnstert.2014.01.023
  7. Hynes RO. Fibronectins. Sci. Am. 1986;254(6):42-51.
  8. Tomasini-Johansson BR, Annis DS, Mosher DF. The N-terminal 70-kDa fragment of fibronectin binds to cell surface fibronectin assembly sites in the absence of intact fibronectin. Matrix Biol. 2006;25(5):282-293.  doi: 10.1016/j.matbio.2006.02.002
  9. Rotterdam EA-SPcwg. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41-47.
  10. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440-1447. doi: 10.1210/jcem-21-11-1440
  11. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672. doi: 10.1210/jcem.84.10.6079
  12. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.  doi: 10.1007/BF00280883
  13. Muolokwu E, Sanchez J, Bercaw JL, et al. Paratubal cysts, obesity, and hyperandrogenism. J Pediatr Surg. 2011;46(11):2164-2167. doi: 10.1016/j.jpedsurg.2011.07.011
  14. Yildiz BO, Azziz R, Androgen E, Androgen excess and PCOS Society. Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the androgen excess and PCOS Society. Fertil Steril. 2010;94(2):690-693.  doi: 10.1016/j.fertnstert.2009.03.058
  15. Juonala M, Magnussen CG, Berenson GS, et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med. 2011;365(20):1876-1885. doi: 10.1056/nejmoa1010112
  16. Rossi B, Sukalich S, Droz J, et al. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. J Clin Endocr Metab. 2008;93(12):4780-4786. doi: 10.1210/jc.2008-1198
  17. Toscani MK, Mario FM, Radavelli-Bagatini S, Spritzer PM. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome. Nutr Res. 2011;31(2):97-103.  doi: 10.1016/j.nutres.2011.01.009
  18. Amato MC, Vesco R, Vigneri E, et al. Hyperinsulinism and polycystic ovary ayndrome (PCOS): role of insulin clearance. J Endocrinol Invest. 2015;38(12):1319-1326. doi: 10.1007/s40618-015-0372-x
  19. Wojciechowski P, Lipowska A, Rys P, et al. Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and metaanalysis. Diabetologia. 2012;55(10):2636-2645. doi: 10.1007/s00125-012-2638-6
  20. Xu N, Kwon S, Abbott DH, et al. Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes on prenatally androgenized rhesus monkeys. PLoS One. 2011;6(11):e27286. doi: 10.1371/journal.pone.0027286
  21. Corbould A. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J Endocrinol. 2007;192(3):585-594.  doi: 10.1677/joe.1.07070
  22. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. The Lancet. 1992;340(8828):1111-1115. doi: 10.1016/0140-6736(92)93147-f

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.